|
Distinguished Faculty
Dimitri Semizarov, Ph.D., Group Leader, Tumor
Genomics, Cancer Discovery,
Abbott
Jeffrey Falk, Ph.D, Director, Technology Applications, Molecular Biology,
Aviva Systems Biology
George H. Perry, Ph.D., Department of Pathology,
Brigham & Women’s Hospital
Angela Keightley, Ph.D., Principal Scientist, Molecular Biology, Laboratory Sciences,
Charles River Laboratories
Tao Wei, Ph.D, Senior Research Scientist, Integrative Biology,
Eli Lilly and Company
David Moskowitz, M.D., CEO,
GenoMed, Inc.
Jo Vandesompele, Ph.D., Center for Medical Genetics,
Ghent University Hospital
Steven Enkemann, Ph.D, Director, Microarray Core Laboratory,
H. Lee Moffitt Cancer Center and Research Institute
Herbert Auer, Director of the Functional Genomics Core,
Institute for Research in Biomedicine
Elisa Mokany, Ph.D, Scientist, Diagnostics,
Johnson & Johnson Research
Stephen Tirrell, Ph.D, Director, Molecular Technologies,
Millennium Pharmaceuticals
Richard Lempicki, Ph.D, Microarray Core Facility Head/Senior Scientist,
Clinic Services Program, NIAID/NIH
Pan Du, Ph.D, Research Associate, Robert H. Lurie Comprehensive Cancer Center,
Northwestern University
Z. Lewis Liu, Ph.D, Research Molecular Biologist,
National Center for Agricultural Utilization Research, USDA-ARS
Jari Rautio, M.Sc, Biotechnology,
VTT
Bharat Joshi, Ph.D., Office of Cellular, Tissue and Gene Therapies
(OCTGT), Division of Cellular and Gene Therapies (DCGT), Tumor Vaccines Biotechnology Branch,
US Food and Drug Administration (FDA)
|